Jinyu Deferred Long Term Liab from 2010 to 2024

600201 Stock   7.01  0.07  1.01%   
Jinyu Bio's Deferred Long Term Liabilities is increasing over the years with slightly volatile fluctuation. Overall, Deferred Long Term Liabilities is expected to go to about 389.5 M this year. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2018-06-30
Previous Quarter
334.5 M
Current Value
343 M
Quarterly Volatility
74.1 M
 
Covid
Check Jinyu Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jinyu Bio's main balance sheet or income statement drivers, such as Interest Expense of 50.7 K, Selling General Administrative of 230.1 M or Total Revenue of 1 B, as well as many indicators such as . Jinyu financial statements analysis is a perfect complement when working with Jinyu Bio Valuation or Volatility modules.
  
This module can also supplement various Jinyu Bio Technical models . Check out the analysis of Jinyu Bio Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

Jinyu Bio financial ratios help investors to determine whether Jinyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinyu with respect to the benefits of owning Jinyu Bio security.